Vertaile menetelmiä
Tarkastele valitsemiasi menetelmiä rinnakkain; eroavat rivit korostetaan.
| Functional Assessment of Cancer Therapy-Breast (FACT-B)× | Edmontonin oirearviointijärjestelmä (ESAS)× | |
|---|---|---|
| Tieteenala | Onkologinen hoitotyö | Onkologinen hoitotyö |
| Menetelmäperhe | Process / pipeline | Process / pipeline |
| Syntyvuosi≠ | 1997 | 1991 |
| Kehittäjä≠ | Marilyn Brady and David Cella | Eduardo Bruera |
| Tyyppi≠ | Patient self-report disease-specific QoL instrument | Patient self-report multisymptom palliative care scale |
| Alkuperäislähde≠ | Brady, M. J., Cella, D. F., Mo, F., et al. (1997). Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol, 15(3), 974–986. DOI ↗ | Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991). The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care, 7(2), 6–9. DOI ↗ |
| Rinnakkaisnimet | FACT-B, FACT-Breast | ESAS, Edmonton Symptom Assessment Scale |
| Liittyvät | 4 | 4 |
| Tiivistelmä≠ | The FACT-B is a comprehensive 36-item disease-specific quality-of-life instrument that integrates the generic FACT-G (27 items covering physical, social, emotional, and functional well-being) with a 9-item breast-cancer-specific subscale addressing body image, sexual function, arm symptoms, and treatment side effects. Developed by Brady et al. in 1997, the FACT-B is the gold-standard QoL measure for breast cancer research and clinical practice, used in hundreds of clinical trials and enabling comparison across breast cancer populations and treatment modalities. | The Edmonton Symptom Assessment System is a rapid, validated 9-item tool that assesses the severity of common symptoms in cancer and palliative care patients: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite loss, general well-being, and shortness of breath. Developed by Bruera and colleagues at the University of Alberta in 1991, the ESAS has become the standard symptom-screening instrument in oncology clinics, palliative care units, and end-of-life care settings worldwide, enabling efficient symptom prioritization and management escalation. |
| ScholarGateAineisto ↗ |
|
|